Unknown

Dataset Information

0

Clinical and dosimetric correlation in terms of treatment response, bladder and rectal toxicities in cervical cancer patients treated with cobalt 60 high dose rate brachytherapy

ABSTRACT:

SUBMITTER: Makkapati B 

PROVIDER: S-EPMC11345003 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Dosimetry evaluation and uncertainty analysis of Cobalt-60 HDR brachytherapy for cervical cancer in resource-limited settings.
| S-EPMC12420530 | biostudies-literature
Unknown Intra-fractional dosimetric analysis of image-guided intracavitary brachytherapy of cervical cancer.
| S-EPMC8335895 | biostudies-literature
Unknown Dosimetric impact of dose constraint indications using individual patient dose management system for brachytherapy in cervical cancer.
| S-EPMC12489536 | biostudies-literature
Unknown Dosimetric divergence in ICBT vs. IC/ISBT configurations: Comparative analysis of three optimization algorithms for cervical cancer brachytherapy.
| S-EPMC12614528 | biostudies-literature
Unknown A dosimetric analysis of rectal hydrogel spacer use in patients with recurrent prostate cancer undergoing salvage high-dose-rate brachytherapy.
| S-EPMC10527788 | biostudies-literature
Unknown Dosimetric Comparison between Three-Dimensional Magnetic Resonance Imaging-Guided and Conventional Two-Dimensional Point A-Based Intracavitary Brachytherapy Planning for Cervical Cancer.
| S-EPMC5017728 | biostudies-literature
Unknown Dosimetric impact of physics libraries for electronic brachytherapy Monte Carlo studies.
| S-EPMC11972044 | biostudies-literature
Unknown Dosimetric characterization of a new directional low-dose rate brachytherapy source.
| S-EPMC6548702 | biostudies-literature
Unknown Source strength determination in iridium-192 and cobalt-60 brachytherapy: A European survey on the level of agreement between clinical measurements and manufacturer certificates.
| S-EPMC8348214 | biostudies-literature
Unknown Clinical and dosimetric experience with MammoSite-based brachytherapy under the RTOG 0413 protocol.
| S-EPMC5722622 | biostudies-literature